// App-Quantinova.ai

390 : Treatment of hepatocellular carcinoma with tyrosine kinase inhibitors: Real-world outcomes from the West of Scotland.

Researchers

Presenter

  • Gregory Naylor

Principal Investigators

  • Alistair McLaren

  • Janet Graham

  • T.R. Jeffry Evans

Medical Centers

  • Beatson WOSCC, Glasgow, United Kingdom

  • Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

  • University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • N/A

Drug/Treatment

  • Regorafenib

  • Lenvatinib

  • Sorafenib

  • L-Tyrosine

Outcome

  • N/A


Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A